Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas
about
HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalphaEmerging roles for HMGB1 protein in immunity, inflammation, and cancerHMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cellsDNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunityEscape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.High-mobility group box 1 and cancer.Expression and effects of high-mobility group box 1 in cervical cancer.A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.Current status of gene expression profiling to assist decision making in stage II colon cancerPrognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas.Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathwayDiagnostic significance of serum HMGB1 in colorectal carcinomasThe association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.HMGB1 in health and disease.Serum HMGB1 as a prognostic marker for malignant pleural mesotheliomaAssociation of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression.High mobility group box-1 and its clinical value in breast cancer.RAGE signaling significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma.The association of HMGB1 gene with the prognosis of HCC.Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2.Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathwayMiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation.HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity.Immunohistochemical study of NF-κB p65, c-IAP2 and caspase-3 expression in cervical cancer.Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population.High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosisRole of HMGB1 in apoptosis-mediated sepsis lethality.Gene Signatures in Stage II Colon Cancer: A Clinical Review.MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinomaRelationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis.HMGB1 silence could promote MCF-7 cell apoptosis and inhibit invasion and metastasis.The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature reviewMicroRNA-218 modulates activities of glioma cells by targeting HMGB1.Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines.The role of high mobility group box 1 (HMGB1) in colorectal cancer.Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer.Cardiovascular disease and high-mobility group box 1--is a new inflammatory killer in town?Dendritic cell defects in the colorectal cancer
P2860
Q24311673-B60210D1-6E25-4295-B51A-7C3CC5F4B5B2Q27015835-D6B3BF62-4DB6-46E4-8158-C22A836E95EFQ28117763-73E187E7-3892-49A6-95DD-D2B4094070A7Q30499197-3037F53E-54B0-4014-90EE-CDF42E673E8BQ33564423-26302FF3-7FE7-4477-A259-03E3D8071013Q33638306-1B413D97-3591-40F2-BEDC-3F3B839F30BBQ33755849-027D1E70-A432-4408-8A78-09D716D5E0D7Q33798500-8BE5EEFF-CFAA-443E-9C3B-F634F90EF505Q33829763-CCA39416-4563-4D0F-8A3C-EE7C4B839C3FQ34019875-F6097BFC-D3C0-4760-AD12-92CCDA503057Q34227734-DDF25FED-0DEA-4CD6-AE9B-828F2D166D7BQ34230026-5B9CB6C6-7B21-44C7-A026-7064A9DC72D9Q34428389-ED436ED3-3E1C-42D2-8041-1D58133DC9ACQ34622835-7D4107DF-6805-4708-BD46-4CBC5E70EB68Q34687224-6D9E6750-B660-4BD1-9F7A-61C5AB41195BQ35025037-53AA52BC-9A98-4784-9843-79162C6F4CBBQ35101004-2026E0A8-B50E-4D5C-B975-A45989D90081Q35102969-B8EE5CD5-7C57-4041-93DA-5958738C07E2Q35106665-0E5B79D2-17B6-4086-9C5C-51A88C84148CQ35172545-02D82121-2A25-4B39-A526-065CA1EA6686Q35562259-020DCD86-A13A-4812-8A04-3C7F7C68A024Q35913266-E9F508AD-4FC6-4C52-BC91-21C67D12757CQ35981607-830CFE8E-F043-4AF1-9C65-129EB5FEF7B4Q35990915-0B50E5D0-4DBC-4E88-8A2F-9037A13B6DF1Q35995652-5B34EDED-7762-48CE-8EA8-39F5DFBF2E4CQ35999764-482878FA-35B8-46C4-9CD0-4F3711C5D5AAQ36190325-F04A2F71-F2EE-4896-8F68-B67402487115Q36228722-8138B886-4598-42C9-9D21-972338A49519Q36247103-A141A798-FE85-4D05-B00D-6674B94395CFQ36261535-6892FDDA-1CD2-401F-A314-F09E20D7D5B2Q36347619-444B402F-0F58-48DB-9C4A-E8615A54C144Q36511773-8D3364BA-3483-40A2-BBC4-96FCA89E9B63Q37170567-78A9D76C-9654-43B4-A9DD-1AB331D77E67Q37293145-763308ED-70C9-4474-9132-E594A579F57BQ37396205-091567B9-BA06-449D-A509-0FC747793F24Q37678815-6CFDA13C-BC7C-475B-9E3E-9C9A49369A11Q37685447-ACFF8CF1-04CD-4B00-BAC3-08C3F6DC9B94Q37825897-A3ECF856-5DA0-43B2-8C97-864FEDC9F2DAQ38040046-47D1E1A8-D701-4909-9A05-EEB08711C4F4Q38284706-CBC45D9C-B46D-4356-A030-EF067576F08A
P2860
Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Increased expression of high m ...... tein in human colon carcinomas
@ast
Increased expression of high m ...... tein in human colon carcinomas
@en
type
label
Increased expression of high m ...... tein in human colon carcinomas
@ast
Increased expression of high m ...... tein in human colon carcinomas
@en
prefLabel
Increased expression of high m ...... tein in human colon carcinomas
@ast
Increased expression of high m ...... tein in human colon carcinomas
@en
P2093
P2860
P356
P1433
P1476
Increased expression of high m ...... tein in human colon carcinomas
@en
P2093
M-L Brezniceanu
T Brabletz
T Kirchner
P2860
P304
P356
10.1136/GUT.2004.062729
P407
P577
2005-08-23T00:00:00Z